Cargando…
S69. A CASE STUDY OF CLOZAPINE AND COGNITION: FRIEND OR FOE?
BACKGROUND: Cognitive dysfunction is as a hallmark feature of schizophrenia. Antipsychotic medication is effective for treating the positive symptoms of psychosis, but their potential for therapeutic effects on cognition continues to divide researchers. Improvements in clinical symptoms can occur in...
Autores principales: | Mezquida, Gisela, Savulich, George, Atkinson, Samuel, Bernardo, Miguel, Fernandez-Egea, Emilio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887394/ http://dx.doi.org/10.1093/schbul/sby018.856 |
Ejemplares similares
-
Human Hemoglobin and Antipsychotics Clozapine, Ziprasidone and Sertindole: Friends or Foes?
por: Platanić Arizanović, Lena, et al.
Publicado: (2023) -
297. Lactobacillus: Friend or Foe
por: Nwanyanwu, Chiemeziem, et al.
Publicado: (2020) -
M60. EARLY VERSUS DELAYED PRESCRIPTION OF CLOZAPINE AND THE COGNITIVE PERFORMANCE ON SCHIZOPHRENIA
por: Amoretti, Silvia, et al.
Publicado: (2020) -
ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
por: Soen, Bieke, et al.
Publicado: (2018) -
Social media and its effect on mental health: Friend or foe?
por: Trivedi, C., et al.
Publicado: (2021)